Related references
Note: Only part of the references are listed.Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis Type II - a family study
Tatsuo Yoneyama et al.
CLINICAL GENETICS (2010)
Creatine kinase brain isoenzyme (BB-CK) presence in serum distinguishes osteopetroses among the sclerosing bone disorders
Michael P. Whyte et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Elevated Serum Lactate Dehydrogenase Isoenzymes and Aspartate Transaminase Distinguish Albers-Schonberg Disease (Chloride Channel 7 Deficiency Osteopetrosis) Among the Sclerosing Bone Disorders
Michael P. Whyte et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Identification of the CLCN7 gene mutations in two Chinese families with autosomal dominant osteopetrosis (type II)
Zhen-Lin Zhang et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2009)
Osteopetrosis
Zornitza Stark et al.
ORPHANET JOURNAL OF RARE DISEASES (2009)
Characteristics of ClC7 Cl- channels and their inhibition in mutant (G215R) associated with autosomal dominant osteopetrosis type II in native osteoclasts and hClcn7 gene-expressing cells
Hiroshi Kajiya et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2009)
Genetics, pathogenesis and complications of osteopetrosis
Andrea Del Fattore et al.
BONE (2008)
Hip axis length changes in 10,554 males and females and the association with femoral neck fracture
Gao Gao et al.
JOURNAL OF CLINICAL DENSITOMETRY (2008)
Association between myostatin gene polymorphisms and peak BMD variation in Chinese nuclear families
Z. -L. Zhang et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Autosomal dominant osteopetrosis: Clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation
Steven G. Waguespack et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
DNA-based diagnosis of malignant osteopetrosis by whole-genome scan using a single-nucleotide polymorphism microarray: standardization of molecular investigations of genetic diseases due to consanguinity
Ching-Wan Lam et al.
JOURNAL OF HUMAN GENETICS (2007)
Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement
Alessandra Pangrazio et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties
Kang Chu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo
K Henriksen et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Analysis of variation in expression of autosomal dominant osteopetrosis type 2: Searching for modifier genes
K Chu et al.
BONE (2005)
Gender differences in bone density at different skeletal sites of acquisition with age in Chinese children and adolescents
XP Wu et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2005)
Mechanisms of disease: Osteopetrosis
J Tolar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Type II benign osteopetrosis (Albers-Schonberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations
C Letizia et al.
CALCIFIED TISSUE INTERNATIONAL (2004)
Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II
SG Waguespack et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human
N Chalhoub et al.
NATURE MEDICINE (2003)
Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density
L Van Wesenbeeck et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis
A Taranta et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the CICN7chloride channel gene
E Cleiren et al.
HUMAN MOLECULAR GENETICS (2001)
Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib
T Mashiba et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)